Immunology of the Small Intestine

Intestinal Failure: Diagnosis, Management and Transplantation

Volumn , Issue , 2009, Pages 33-44

  O'Mahony, Liam ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cellular basis of immunological tolerance; Intestinal immune signaling and bacterial flora; Molecular basis underpinning antigen recognition; Organized GALT; Small intestine immunology; Toll like receptors (TLRs); Understanding small intestinal immunology

Indexed keywords

EID: 84889483368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781405195805.ch4     Document Type: Chapter

References (38)

1. Brandtzaeg P, Pabst R. Let's gomucosal: communication on slippery ground. Trends Immunol 2004;25:570-577.
2. Gebert A, Rothkotter HJ, Pabst R. M cells in Peyer's patches of the intestine. Int Rev Cytol 1996;167:91-159.
3. Brandtzaeg P, Baekkevold ES, Farstad IN, et al. Regional specialization in the mucosal immune system:what happens in the micro-compartments? Immunol Today 1999;20:141-151.
4. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001;166:4884-4890.
5. Iwasaki A, Kelsall BL. Localisation of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000;191:1381-1394.
6. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-1665.
7. Zhao H, Nguyen H, Kang J. Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes. Nat Immunol 2005;6:1263-1271.
8. Hayday A, Theodoridis E, Ramsburg E, Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001;2:997-1003.
9. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005;129:1294-1301.
10. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-367.
11. Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A two separate but related systems of immune defense? Ann Intern Med 1987;106:892-899.
12. Macpherson AJ, Hunziker L, McCoy K, Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 2001;3:1021-1035.
13. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-514.
14. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53:1658-1664.
15. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
16. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-458.
17. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J Biol Chem 2003;275:5509-5512.
18. Koppel EA, van Gisbergen K, Geijtenbeek TBH, van Kooyk Y. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol 2005;7:157-165.
19. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immuol 2005;6:280-286.
20. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
21. Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001;167:188-195.
22. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity 2001;14:145-155.
23. Mellor AL, Chandler P, Baban B, et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int Immunol 2004;23:1391-1401.
24. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996;183:2669-2674.
25. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
26. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 Functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
27. Wirtz S, Neyrath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 2000;15:144-160.
28. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-267.
29. Duchmann R, Kaiser I, Mayet W, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-455.
30. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84:282-291.
31. Iwasaki T. Recent advances in the treatment of Graft-Versus-Host Disease. Clin Med Res 2004;2:243-252.
32. Pirenne J, Kawai M. Tolerogenic protocols for intestinal transplantation. Transplant Immunol 2004;13:131-137.
33. Pirenne J, Koshiba T, Geboes K. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002;73:966-968.
34. Macpherson AJ, Harris N. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004;4:478-485.
35. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-980.
36. O'Mahony L, O'Callaghan L, McCarthy J, et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2006;290:839-845.
37. Shanahan F. Probiotics in inflammatory bowel disease-therapeutic rationale and role. Adv Drug Deliv Rev 2004;56:809-818.
38. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-551.